BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Starosyla SA, Volynets GP, Bdzhola VG, Golub AG, Yarmoluk SM. Pharmacophore approaches in protein kinase inhibitors design. World J Pharmacol 2014; 3(4): 162-173 [DOI: 10.5497/wjp.v3.i4.162]
URL: https://www.wjgnet.com/2220-3192/full/v3/i4/162.htm
Number Citing Articles
1
Khaled El‐Adl, Helmy Sakr, Mohamed Nasser, Mohamed Alswah, Fatma M. A. Shoman. 5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluationsArchiv der Pharmazie 2020; 353(9): 2000079 doi: 10.1002/ardp.202000079
2
Domiziana Masci, Charlotte Hind, Mohammad K. Islam, Anita Toscani, Melanie Clifford, Antonio Coluccia, Irene Conforti, Meir Touitou, Siham Memdouh, Xumin Wei, Giuseppe La Regina, Romano Silvestri, J. Mark Sutton, Daniele Castagnolo. Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studiesEuropean Journal of Medicinal Chemistry 2019; 178: 500 doi: 10.1016/j.ejmech.2019.05.087
3
Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Sanadelaslam S. A. El‐Hddad. Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1 H ,3 H )‐dione bearing different moieties as VEGFR‐2 inhibitors Archiv der Pharmazie 2020; 353(8): 2000068 doi: 10.1002/ardp.202000068
4
Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Fathalla Khedr, Hamada S. Abulkhair, Ibrahim H. Eissa. N ‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies Archiv der Pharmazie 2021; 354(3): 2000219 doi: 10.1002/ardp.202000219
5
Mykola V. Protopopov, Olga V. Ostrynska, Sergiy A. Starosyla, Maria A. Vodolazhenko, Svetlana M. Sirko, Nikolay Yu. Gorobets, Volodymyr Bdzhola, Sergey M. Desenko, Sergiy M. Yarmoluk. Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitorsMolecular Diversity 2018; 22(4): 991 doi: 10.1007/s11030-018-9836-1